View the event
| Reference: | 3808 |
| Country: | Uzbekistan |
| Multiple country event: | No |
| Region: | EURO |
| City: | Tashkent |
| Start date: | 9 September 2011 |
| End date: | 15 September 2011 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | Project Assessment Visit |
| Type: | Mission |
| Terms of Reference: | Terms of Reference
Consultation Visit: Dr. Fabio Luelmo
August 28 – September 18
1. Background
The Central Asian Republics are among the countries with the highest burden of multidrug resistant tuberculosis in the world. While international inputs for TB control throughout the region are substantial the MDR situation has been rapidly worsening despite some signs of stabilization of the epidemic in each country.
USAID has launched new Quality Health Care Project implemented by Abt Associates, Project HOPE, and the consortium of other agencies. The project is a broad project which is focused on improving the Quality of care throughout the health system including the PHC, and vertical TB and HIV systems. USAID and the Quality project are working to improve integration and to work as a catalyst to rapidly move the region towards fully ambulatory care which will allow the TB system to focus more fully on MDR TB cases.
Note: In all countries of the region there are more MDR TB cases than there are available quality assured 2nd line drugs, adequate diagnostic capacity, and adequate clinical capacity to manage these cases.
2. Goal and Approach
Review the current situation related to MDR TB including linkages between inpatient and outpatient/PHC treatment and make recommendations related to scaling-up MDR treatment and the role of outpatient/PHC treatment in Kyrgyzstan, Tajikistan, and Uzbekistan.
Assess current country capacity to expand out-patient treatment and provide recommendations on the way forward.
The review should include consideration of the current gap in capacity in each country to cover the current number of MDR patients and the availability of quality assured 2nd line drugs, diagnostic capacity, and clinical capacity to treat MDR cases.
3. Required Products
• Debriefing USAID Regional Mission on initial findings and recommendations;
• Within 2 weeks upon completion of mission in the country, the consultant should prepare report with findings and recommendations
4. Travel Agenda:
August 27 Arrival: Almaty
August 28th – Briefing Almaty
Aug. 29th – Fly to Tajikistan
September 3rd - Fly to Kyrgyzstan
September 9th – 15th: Uzbekistan
September 15th: Travel to Kazakhstan / Debriefing
Deliverables: Trip report with recommendation due within two weeks of the conclusion of the consultation visit.
|
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | Other |
| Purpose 3: | |
| Other purpose: | PHC / Vertical TB Sytem Integration |
|
| Entered by: | Project Hope |
| Partner 1: | USAID |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Tom Mohr |
| Contact email: | tmohr@projecthope.org |
| Other agencies: | Abt Associates |
|
| Funding needs: | No |
| Funding source: | USAID |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | |
| |
There are no documents attached associated with this event. There are no experts (roster) associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 10 October 2011
Entered By: Project Hope
|
